New Key Statistics Module, Z-Score and F-Score
NAS:BPMC Key Ratios
Market Cap $ M | 5,442.71 |
Enterprise Value $ M | 5,033.57 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 41.54 |
Price/Sales | 20.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 249.00 |
EPS (TTM) $ | -8.36 |
Beneish M-Score | -2.91 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.32 |
EV-to-EBITDA | -10.58 |
PEG | -- |
Shares Outstanding M | 61.23 |
Net Margin (%) | -203.30 |
Operating Margin % | -193.29 |
Pre-tax Margin (%) | -202.91 |
Quick Ratio | 3.66 |
Current Ratio | 3.76 |
ROA % (ttm) | -43.47 |
ROE % (ttm) | -161.12 |
ROIC % (ttm) | -120.60 |
Dividend Yield % | -- |
Altman Z-Score | -0.15 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
BPMC Number of Guru Trades
BPMC Volume of Guru Trades
Gurus Latest Trades with NAS:BPMC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BPMC is held by these investors
Total 3
Blueprint Medicines Corp Insider Transactions
No Available Data
News about NAS:BPMC
Total 0- 1